Delgado Mercedes, Fernández-Alfonso M Soledad, Fuentes Angel
Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, Avda. Juan XXIII no. 1, 28040 Madrid, Spain.
Arch Dermatol Res. 2002 Jul;294(4):190-7. doi: 10.1007/s00403-002-0313-3. Epub 2002 Jun 4.
An increase in phosphodiesterase 4 (PDE4) in blood mononuclear white cells of patients with atopic dermatitis (AD) has been described. This and other skin disorders worsen during stress, during which there are increased circulating levels of adrenaline and glucocorticoids. The aim of this study was to analyse the effect of both these hormones on PDE4 in inflammatory cells. The human monocyte cell line U-937 was used as a model of blood mononuclear leucocytes. For this purpose, (1) the effect of adrenaline on PDE4 activity was determined, (2) the receptor mediating adrenaline actions was characterized, (3) the role of intracellular cAMP in PDE4 activation was investigated and (4) the effect of glucocorticoids on PDE4 activity was also ascertained. Adrenaline at a concentration of 1 micro M produced a two- to threefold selective increase in PDE4 activity in U-937 cells after 4 h of incubation with the hormone. This stimulation was reversible, as well as concentration- and time-dependent. Cycloheximide (10 micro M) induced a blockade of adrenaline-induced stimulation of PDE4. The stimulatory effect was inhibited by propranolol, but not by atenolol or phentolamine, in a concentration-dependent manner and was mimicked by salbutamol. The stimulation of PDE4 was paralleled by an increase in intracellular levels of cAMP. 8-Br-cAMP and forskolin also increased PDE4 activity. After 4 h of incubation in the presence of adrenaline, inhibition of cAMP degradation by rolipram further increased cAMP levels by about 300% and also enhanced PDE4 activity. These results suggest that adrenaline-induced stimulation of PDE4 is mediated by the beta(2)-adrenoceptor and is related to intracellular levels of cAMP, which might trigger expression and synthesis of the enzyme. The synthetic glucocorticoid dexamethasone (in the concentration range 10(-8) to 10(-6) M) showed no effect on PDE4 activity or on the cAMP accumulation induced by adrenaline, even after prolonged (24 h) incubation with the cells. Of the two stress hormones assayed, PDE4 activity was shown to be sensitive to adrenaline elevation but resistant to changes in glucocorticoid levels in the U-937 monocytic cell line.
已有研究报道,特应性皮炎(AD)患者血液单核白细胞中的磷酸二酯酶4(PDE4)增加。这种疾病以及其他皮肤疾病在压力状态下会恶化,在此期间,肾上腺素和糖皮质激素的循环水平会升高。本研究的目的是分析这两种激素对炎症细胞中PDE4的影响。人类单核细胞系U - 937被用作血液单核白细胞的模型。为此,(1)测定了肾上腺素对PDE4活性的影响,(2)对介导肾上腺素作用的受体进行了表征,(3)研究了细胞内cAMP在PDE4激活中的作用,(4)还确定了糖皮质激素对PDE4活性的影响。在与该激素孵育4小时后,浓度为1微摩尔的肾上腺素使U - 937细胞中PDE4活性选择性增加了两到三倍。这种刺激是可逆的,且具有浓度和时间依赖性。放线菌酮(10微摩尔)可阻断肾上腺素对PDE4的诱导刺激。普萘洛尔以浓度依赖的方式抑制了这种刺激作用,而阿替洛尔或酚妥拉明则无此作用,沙丁胺醇可模拟这种刺激作用。PDE4的刺激伴随着细胞内cAMP水平的升高。8 - 溴 - cAMP和福斯高林也可增加PDE4活性。在肾上腺素存在下孵育4小时后,罗匹尼罗抑制cAMP降解可使cAMP水平进一步升高约300%,同时也增强了PDE4活性。这些结果表明,肾上腺素诱导的PDE4刺激是由β(2)-肾上腺素能受体介导的,并且与细胞内cAMP水平有关,这可能会触发该酶的表达和合成。合成糖皮质激素地塞米松(浓度范围为10(-8)至10(-6) M)即使在与细胞长时间(24小时)孵育后,对PDE4活性或肾上腺素诱导的cAMP积累也无影响。在所检测的两种应激激素中,PDE4活性在U - 937单核细胞系中对肾上腺素升高敏感,但对糖皮质激素水平变化具有抗性。